MEDLINE INC-CL A (MDLN) Fundamental Analysis & Valuation

NASDAQ:MDLN • US58507V1070

Current stock price

42.17 USD
+0.14 (+0.33%)
Last:

This MDLN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MDLN Profitability Analysis

1.1 Basic Checks

  • MDLN had positive earnings in the past year.
  • In the past year MDLN had a positive cash flow from operations.
MDLN Yearly Net Income VS EBIT VS OCF VS FCFMDLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 500M 1B 1.5B 2B

1.2 Ratios

  • The Return On Assets of MDLN (3.01%) is better than 75.13% of its industry peers.
  • MDLN's Return On Equity of 10.79% is amongst the best of the industry. MDLN outperforms 85.19% of its industry peers.
  • MDLN's Return On Invested Capital of 4.86% is fine compared to the rest of the industry. MDLN outperforms 75.13% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MDLN is below the industry average of 9.31%.
  • The 3 year average ROIC (4.55%) for MDLN is below the current ROIC(4.86%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.01%
ROE 10.79%
ROIC 4.86%
ROA(3y)2.33%
ROA(5y)N/A
ROE(3y)6.48%
ROE(5y)N/A
ROIC(3y)4.55%
ROIC(5y)N/A
MDLN Yearly ROA, ROE, ROICMDLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • The Profit Margin of MDLN (4.08%) is better than 76.19% of its industry peers.
  • MDLN has a better Operating Margin (7.79%) than 74.07% of its industry peers.
  • MDLN's Operating Margin has improved in the last couple of years.
  • The Gross Margin of MDLN (26.44%) is worse than 77.25% of its industry peers.
  • In the last couple of years the Gross Margin of MDLN has grown nicely.
Industry RankSector Rank
OM 7.79%
PM (TTM) 4.08%
GM 26.44%
OM growth 3Y26.77%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5YN/A
MDLN Yearly Profit, Operating, Gross MarginsMDLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MDLN Health Analysis

2.1 Basic Checks

  • MDLN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, MDLN has about the same amount of shares outstanding.
  • MDLN has a better debt/assets ratio than last year.
MDLN Yearly Shares OutstandingMDLN Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 200M 400M 600M 800M 1B
MDLN Yearly Total Debt VS Total AssetsMDLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • MDLN has an Altman-Z score of 2.38. This is not the best score and indicates that MDLN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • MDLN has a better Altman-Z score (2.38) than 66.67% of its industry peers.
  • MDLN has a debt to FCF ratio of 9.68. This is a negative value and a sign of low solvency as MDLN would need 9.68 years to pay back of all of its debts.
  • MDLN has a better Debt to FCF ratio (9.68) than 73.55% of its industry peers.
  • A Debt/Equity ratio of 1.16 is on the high side and indicates that MDLN has dependencies on debt financing.
  • MDLN has a worse Debt to Equity ratio (1.16) than 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 9.68
Altman-Z 2.38
ROIC/WACC0.46
WACC10.48%
MDLN Yearly LT Debt VS Equity VS FCFMDLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • MDLN has a Current Ratio of 4.29. This indicates that MDLN is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 4.29, MDLN is doing good in the industry, outperforming 69.31% of the companies in the same industry.
  • A Quick Ratio of 2.37 indicates that MDLN has no problem at all paying its short term obligations.
  • The Quick ratio of MDLN (2.37) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.29
Quick Ratio 2.37
MDLN Yearly Current Assets VS Current LiabilitesMDLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. MDLN Growth Analysis

3.1 Past

  • The earnings per share for MDLN have decreased by -3.42% in the last year.
  • MDLN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.47%.
  • Measured over the past years, MDLN shows a quite strong growth in Revenue. The Revenue has been growing by 9.85% on average per year.
EPS 1Y (TTM)-3.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)11.47%
Revenue growth 3Y9.85%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, MDLN will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.44% on average per year.
  • The Revenue is expected to grow by 8.35% on average over the next years. This is quite good.
EPS Next Y20.98%
EPS Next 2Y16.57%
EPS Next 3Y15.44%
EPS Next 5YN/A
Revenue Next Year9.73%
Revenue Next 2Y8.7%
Revenue Next 3Y8.35%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MDLN Yearly Revenue VS EstimatesMDLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
MDLN Yearly EPS VS EstimatesMDLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. MDLN Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 47.92, the valuation of MDLN can be described as expensive.
  • Based on the Price/Earnings ratio, MDLN is valued a bit cheaper than the industry average as 68.25% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of MDLN to the average of the S&P500 Index (25.50), we can say MDLN is valued expensively.
  • The Price/Forward Earnings ratio is 28.25, which means the current valuation is very expensive for MDLN.
  • Based on the Price/Forward Earnings ratio, MDLN is valued a bit cheaper than 71.43% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of MDLN to the average of the S&P500 Index (22.67), we can say MDLN is valued slightly more expensively.
Industry RankSector Rank
PE 47.92
Fwd PE 28.25
MDLN Price Earnings VS Forward Price EarningsMDLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • MDLN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MDLN is cheaper than 74.07% of the companies in the same industry.
  • MDLN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MDLN is cheaper than 75.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.71
EV/EBITDA 20.41
MDLN Per share dataMDLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MDLN does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as MDLN's earnings are expected to grow with 15.44% in the coming years.
PEG (NY)2.28
PEG (5Y)N/A
EPS Next 2Y16.57%
EPS Next 3Y15.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MDLN Dividend Analysis

5.1 Amount

  • MDLN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MDLN Fundamentals: All Metrics, Ratios and Statistics

MEDLINE INC-CL A

NASDAQ:MDLN (3/25/2026, 9:50:09 AM)

42.17

+0.14 (+0.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25
Earnings (Next)N/A
Inst Owners52.42%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner Change-6.03%
Market Cap55.40B
Revenue(TTM)28.43B
Net Income(TTM)1.16B
Analysts83.53
Price Target48.27 (14.47%)
Short Float %1.87%
Short Ratio1.72
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.43%
PT rev (3m)N/A
EPS NQ rev (1m)1.31%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.21%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.9%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.11%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 47.92
Fwd PE 28.25
P/S 1.95
P/FCF 42.71
P/OCF 31.77
P/B 5.16
P/tB N/A
EV/EBITDA 20.41
EPS(TTM)0.88
EY2.09%
EPS(NY)1.49
Fwd EY3.54%
FCF(TTM)0.99
FCFY2.34%
OCF(TTM)1.33
OCFY3.15%
SpS21.64
BVpS8.17
TBVpS-8.55
PEG (NY)2.28
PEG (5Y)N/A
Graham Number12.72
Profitability
Industry RankSector Rank
ROA 3.01%
ROE 10.79%
ROCE 6.15%
ROIC 4.86%
ROICexc 5.14%
ROICexgc 14.47%
OM 7.79%
PM (TTM) 4.08%
GM 26.44%
FCFM 4.56%
ROA(3y)2.33%
ROA(5y)N/A
ROE(3y)6.48%
ROE(5y)N/A
ROIC(3y)4.55%
ROIC(5y)N/A
ROICexc(3y)4.71%
ROICexc(5y)N/A
ROICexgc(3y)14.23%
ROICexgc(5y)N/A
ROCE(3y)5.76%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y26.77%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5YN/A
F-Score6
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 9.68
Debt/EBITDA 3.87
Cap/Depr 44.21%
Cap/Sales 1.57%
Interest Coverage 2.35
Cash Conversion 54.08%
Profit Quality 111.91%
Current Ratio 4.29
Quick Ratio 2.37
Altman-Z 2.38
F-Score6
WACC10.48%
ROIC/WACC0.46
Cap/Depr(3y)36.45%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.38%
Cap/Sales(5y)N/A
Profit Quality(3y)277.46%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y20.98%
EPS Next 2Y16.57%
EPS Next 3Y15.44%
EPS Next 5YN/A
Revenue 1Y (TTM)11.47%
Revenue growth 3Y9.85%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year9.73%
Revenue Next 2Y8.7%
Revenue Next 3Y8.35%
Revenue Next 5YN/A
EBIT growth 1Y1.48%
EBIT growth 3Y39.25%
EBIT growth 5YN/A
EBIT Next Year22.35%
EBIT Next 3Y13.23%
EBIT Next 5YN/A
FCF growth 1Y-8.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.41%
OCF growth 3YN/A
OCF growth 5YN/A

MEDLINE INC-CL A / MDLN Fundamental Analysis FAQ

What is the fundamental rating for MDLN stock?

ChartMill assigns a fundamental rating of 4 / 10 to MDLN.


What is the valuation status of MEDLINE INC-CL A (MDLN) stock?

ChartMill assigns a valuation rating of 3 / 10 to MEDLINE INC-CL A (MDLN). This can be considered as Overvalued.


How profitable is MEDLINE INC-CL A (MDLN) stock?

MEDLINE INC-CL A (MDLN) has a profitability rating of 5 / 10.


What is the expected EPS growth for MEDLINE INC-CL A (MDLN) stock?

The Earnings per Share (EPS) of MEDLINE INC-CL A (MDLN) is expected to grow by 20.98% in the next year.